(13:42 GMT) Kiniksa Pharmaceuticals Price Target Raised to $72.00/Share From $59.00 by Wedbush
Dow Jones Newswires
Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:KNSA
- Language
- English